Related references
Note: Only part of the references are listed.High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia:: a Cancer and Leukemia Group B (CALGB) study
Christian Langer et al.
BLOOD (2008)
MiR-126 regulates angiogenic signaling and vascular integrity
Jason E. Fish et al.
DEVELOPMENTAL CELL (2008)
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis
Shusheng Wang et al.
DEVELOPMENTAL CELL (2008)
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study
Peter Paschka et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study
Guido Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells
Alla Musiyenko et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
MicroRNA expression in cytogenetically normal acute myeloid leukemia
Guido Marcucci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications
Susan P. Whitman et al.
BLOOD (2008)
The known unknowns of antigen processing and presentation
Jatin M. Vyas et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation
A. Rosa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MNI overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML
Michael Heuser et al.
BLOOD (2007)
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia:: A Cancer and Leukemia Group B study
Guido Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
MN1 overexpression is an important step in the development of inv(16) AML
C. Carella et al.
LEUKEMIA (2007)
A phase III randomized trial of intensive induction and consolidation chemotherapy ± oblimersen, a pro-apoptotic Bcl-2 antisense oligonucleotide in untreated acute myeloid leukemia patients >60 years old
G. Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication:: a Cancer and Leukemia Group B study
Susan P. Whitman et al.
BLOOD (2007)
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics:: are we ready for a prognostically prioritized molecular classification?
Krzysztof Mrozek et al.
BLOOD (2007)
High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics
Michael Heuser et al.
BLOOD (2006)
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype:: a Cancer and Leukemia Group B study
Michael D. Radmacher et al.
BLOOD (2006)
MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice
C. Carella et al.
LEUKEMIA (2006)
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype:: A cancer and leukemia group B study
G Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML):: association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
RGW Verhaak et al.
BLOOD (2005)
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations
K Döhner et al.
BLOOD (2005)
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
Y Hayashita et al.
CANCER RESEARCH (2005)
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
GA Calin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
c-Myc-regulated microRNAs modulate E2F1 expression
KA O'Donnell et al.
NATURE (2005)
The 1,25(OH)(2)D-3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation
ALM Sutton et al.
MOLECULAR ENDOCRINOLOGY (2005)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: Final induction results of cancer and leukemia group B study 9621
JE Kolitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics:: a Cancer and Leukemia Group B Study
CD Baldus et al.
BLOOD (2003)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription
KHM van Wely et al.
ONCOGENE (2003)
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461)
JC Byrd et al.
BLOOD (2002)
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia:: association with FAB subtypes and identification of subgroups with poor prognosis
C Thiede et al.
BLOOD (2002)
GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways
KD Dahlquist et al.
NATURE GENETICS (2002)
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Y Yamamoto et al.
BLOOD (2001)
Share Paper
